| ID | 118 |
|---|
| No | 118 |
|---|
| Brand Name | GLYCIKAM SR G2 |
|---|
| Ingredients | METFORMIN HYDROCHLORIDE BP 500 MG, GLIMEPIRIDE BP 2 MG |
|---|
| Dosage Form | PROLONGED RELEASE TABLET |
|---|
| Primary Packaging | ALU-ALU BLISTER |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 3 X 10'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETE WHO ARE ALREADY TREATED WITH COMBINATION OF GLIMEPIRID AND METFORMIN OR WHOSE DIABETES IS NOT ADEQUATELY CONTROLLED WITH METFORMIN ALONE. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | ORANGE AND WHITE COLORED, CAPSULE SHAPED, BICONVEX UNCOATED BILAYERED TABLETS HAVING BREAKLINE ON ONE SIDE AND PLAIN ON THE OTHER |
|---|
| Note | |
|---|
| License Owner | ASA LAO SOLE COMPANY LIMITED |
|---|
| Manufacturer | IMPULSE PHARMA PVT. LTD |
|---|
| Country | INDIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 09 I 5797/24 |
|---|
| FDD Registration Date | 25/09/2024 |
|---|
| Expiry Date | 24/09/2029 |
|---|
